tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Adele Palama, 9 are a BUY (81.82%), 2 are a HOLD (18.18%).
Analyst Adele Palama, currently employed at UBS, carries an average stock price target met ratio of 66.67% that have a potential upside of 38.77% achieved within 573 days.
Adele Palama’s has documented 21 price targets and ratings displayed on 4 stocks. The coverage is on Energy, Industrials, Healthcare sectors.
Most recent stock forecast was given on FC, Franklin Covey Company at 22-Feb-2023.
Analyst best performing recommendations are on MD (MEDNAX).
The best stock recommendation documented was for MD (MEDNAX) at 11/1/2022. The price target of $8.98 was fulfilled within 380 days with a profit of $10.56 (54.04%) receiving and performance score of 1.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
What Year was the first public recommendation made by Adele Palama?
